Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Lock-Up Expiration Hell Portfolio -- Ignore unavailable to you. Want to Upgrade?

To: tuck who wrote (535)	12/11/2001 9:27:55 PM
From: keokalani'nui	Read Replies (1) \| Respond to of 1005

Here's your chance with that RIGL truck..... Rigel Pharmaceuticals files $50 mln mixed shelf WASHINGTON, Dec 11 (Reuters) - Drug developer Rigel Pharmaceuticals Inc. (NasdaqNM:RIGL - news) on Tuesday filed with federal regulators to periodically sell up to $50 million in common and preferred stock, debt securities and warrants. In a filing with the Securities and Exchange Commission, the South San Francisco-based company said it plans to use the proceeds from the shelf offering for research and development. It may also use the money for general corporate purposes, acquisitions and investments, according to the SEC filing. Its shares closed 6 cents higher at $4.56 on Nasdaq. Hard to fault them, they need more cash. Hope they have some nice news planned for cover, though it didn't help btrn much, eh? As for the possibility of debt.....they are joking I hope. Wilder